Lupin Launches Ranluspec Biosimilar Across European Markets!
Mumbai, India, November 12, 2026 Lupin Limited has announced the European commercial launch of Ranluspec™ (ranibizumab), its biosimilar medicine...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Mumbai, India, November 12, 2026 Lupin Limited has announced the European commercial launch of Ranluspec™ (ranibizumab), its biosimilar medicine...
Indianapolis, Indiana, United States, November 10, 2026 Eli Lilly and Company has announced the launch of a new patient-focused...
LeĂłn, Spain, November 9, 2026 Curia Global, Inc., a global contract research, development and manufacturing organization (CDMO), has announced...
Tel Aviv, Israel, November 3, 2026 Teva Pharmaceutical Industries Ltd. has reported strong growth across its three key innovative...
Mumbai, India, and Naples, Florida, USA, November 2, 2026 Lupin Limited, a global pharmaceutical company, has announced that it...
Vancouver, British Columbia, September 23, 2026 Zymeworks Inc. has completed its previously announced acquisition of Theravance Biopharma, Inc., bringing...
Aachen, Germany, September 21, 2026 Grünenthal has announced an agreement with Bayer AG to acquire Stivarga® (regorafenib), an established...
BAGSVAERD, Denmark — September 14, 2026 Novo Nordisk A/S announced the launch of a new corporate brand centred on...
Cambridge, Massachusetts, USA, September 8, 2026 LabCentral has launched The Loop, a new program designed to help international biotech...
Bailly-Romainvilliers, France — September 3, 2026 Resonant Clinical Solutions announced the acquisition of Creapharm Bioservices from Myonex, strengthening its...
